| Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
U266-B1 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
OCI-MY5 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
OCI-MY5 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
OCI-MY5 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
OCI-MY5 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
MM-1R |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
MM-1R |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
MM-1R |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
MM-1R |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
RPMI-8266 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
RPMI-8266 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
6.00 µM |
RPMI-8266 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
RPMI-8266 |
Homo sapiens |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
1.00 µM |
MM |
Homo sapiens (patient) |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
2.00 µM |
MM |
Homo sapiens (patient) |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
4.00 µM |
MM |
Homo sapiens (patient) |
|
|
|
| Atiprimod |
Influence on cell viability |
MTT Assay |
8.00 µM |
MM |
Homo sapiens (patient) |
|
|
|
